25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biotest Aktiengesellschaft
Buy, Hold or Sell?

Let's analyze Biotest together

I guess you are interested in Biotest Aktiengesellschaft. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotest Aktiengesellschaft. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.

1. Quick Overview

1.1. Quick analysis of Biotest (30 sec.)










1.2. What can you expect buying and holding a share of Biotest? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
€13.54
Expected worth in 1 year
€17.65
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
€4.10
Return On Investment
15.7%

For what price can you sell your share?

Current Price per Share
€26.20
Expected price per share
€24.80 - €26.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biotest (5 min.)




Live pricePrice per Share (EOD)
€26.20
Intrinsic Value Per Share
€63.73 - €76.90
Total Value Per Share
€77.27 - €90.45

2.2. Growth of Biotest (5 min.)




Is Biotest growing?

Current yearPrevious yearGrowGrow %
How rich?$581.1m$390.2m$158m28.8%

How much money is Biotest making?

Current yearPrevious yearGrowGrow %
Making money$52.1m-$2.7m$54.8m105.2%
Net Profit Margin21.5%-3.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Biotest (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#99 / 958

Most Revenue
#46 / 958

Most Profit
#29 / 958
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biotest?

Welcome investor! Biotest's management wants to use your money to grow the business. In return you get a share of Biotest.

First you should know what it really means to hold a share of Biotest. And how you can make/lose money.

Speculation

The Price per Share of Biotest is €26.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotest.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotest, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €13.54. Based on the TTM, the Book Value Change Per Share is €1.03 per quarter. Based on the YOY, the Book Value Change Per Share is €0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotest.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.271.0%1.325.0%0.361.4%0.140.5%0.140.5%
Usd Book Value Change Per Share0.220.8%1.114.2%0.100.4%0.732.8%0.732.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.220.8%1.114.2%0.100.4%0.742.8%0.742.8%
Usd Price Per Share28.41-31.18-35.62-32.04-32.04-
Price to Earnings Ratio26.72-11.55-5.06--19.93--19.93-
Price-to-Total Gains Ratio129.60-52.84--11.80--83.33--83.33-
Price to Book Ratio1.93-2.27-3.62-2.77-2.77-
Price-to-Total Gains Ratio129.60-52.84--11.80--83.33--83.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share28.41128
Number of shares35
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share1.110.73
Usd Total Gains Per Share1.110.74
Gains per Quarter (35 shares)38.9426.02
Gains per Year (35 shares)155.76104.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10156146110394
203123023206198
304674584308302
406236145411406
507797706514510
609359268617614
70109010829720718
801246123810822822
901402139411925926
100155815501310281030

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%7.05.00.058.3%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
Book Value Change Per Share4.00.00.0100.0%6.06.00.050.0%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
Dividend per Share0.00.04.00.0%2.00.010.016.7%8.00.012.040.0%8.00.012.040.0%8.00.012.040.0%
Total Gains per Share4.00.00.0100.0%6.06.00.050.0%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biotest Aktiengesellschaft compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2021.026-80%0.094+116%0.677-70%0.677-70%
Book Value Per Share--13.54312.778+6%9.094+49%11.511+18%11.511+18%
Current Ratio--2.4532.863-14%4.741-48%4.430-45%4.430-45%
Debt To Asset Ratio--0.6100.638-4%0.693-12%0.636-4%0.636-4%
Debt To Equity Ratio--1.5671.768-11%2.255-31%1.782-12%1.782-12%
Dividend Per Share----0%-0%0.008-100%0.008-100%
Eps--0.2451.214-80%0.330-26%0.131+87%0.131+87%
Free Cash Flow Per Share--1.4760.540+173%-0.926+163%0.108+1263%0.108+1263%
Free Cash Flow To Equity Per Share--1.4760.540+173%-0.972+166%0.173+752%0.173+752%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--76.904--------
Intrinsic Value_10Y_min--63.731--------
Intrinsic Value_1Y_max--0.896--------
Intrinsic Value_1Y_min--0.876--------
Intrinsic Value_3Y_max--7.883--------
Intrinsic Value_3Y_min--7.421--------
Intrinsic Value_5Y_max--21.127--------
Intrinsic Value_5Y_min--19.163--------
Market Cap518385340.000-100%1036772042.4001137679245.000-9%1299922198.200-20%1147304972.164-10%1147304972.164-10%
Net Profit Margin--0.0620.215-71%-0.038+161%-0.014+122%-0.014+122%
Operating Margin----0%0.023-100%-0.0220%-0.0220%
Operating Ratio--1.5111.328+14%1.740-13%1.698-11%1.698-11%
Pb Ratio1.9350%1.9352.269-15%3.617-47%2.766-30%2.766-30%
Pe Ratio26.7210%26.72111.550+131%5.056+429%-19.929+175%-19.929+175%
Price Per Share26.2000%26.20028.750-9%32.850-20%29.542-11%29.542-11%
Price To Free Cash Flow Ratio4.4380%4.43811.271-61%-10.252+331%3.247+37%3.247+37%
Price To Total Gains Ratio129.5970%129.59752.836+145%-11.805+109%-83.328+164%-83.328+164%
Quick Ratio--0.4970.743-33%1.312-62%1.337-63%1.337-63%
Return On Assets--0.0070.035-80%-0.003+136%0.001+578%0.001+578%
Return On Equity--0.0180.100-82%-0.008+146%0.003+420%0.003+420%
Total Gains Per Share--0.2021.026-80%0.094+116%0.685-71%0.685-71%
Usd Book Value--581129960.000548326860.000+6%390248450.000+49%467295070.000+24%467295070.000+24%
Usd Book Value Change Per Share--0.2191.113-80%0.101+116%0.734-70%0.734-70%
Usd Book Value Per Share--14.68613.857+6%9.862+49%12.483+18%12.483+18%
Usd Dividend Per Share----0%-0%0.009-100%0.009-100%
Usd Eps--0.2661.317-80%0.358-26%0.142+87%0.142+87%
Usd Free Cash Flow--63328960.00023179050.000+173%-39716150.000+163%5909980.000+972%5909980.000+972%
Usd Free Cash Flow Per Share--1.6000.586+173%-1.004+163%0.117+1263%0.117+1263%
Usd Free Cash Flow To Equity Per Share--1.6000.586+173%-1.054+166%0.188+752%0.188+752%
Usd Market Cap562137062.696-100%1124275602.7791233699373.278-9%1409635631.728-20%1244137511.815-10%1244137511.815-10%
Usd Price Per Share28.4110%28.41131.177-9%35.623-20%32.035-11%32.035-11%
Usd Profit--10518680.00052105420.000-80%-2711000.000+126%3301998.000+219%3301998.000+219%
Usd Revenue--170033920.000219347010.000-22%145906020.000+17%153128124.000+11%153128124.000+11%
Usd Total Gains Per Share--0.2191.113-80%0.101+116%0.743-71%0.743-71%
 EOD+0 -2MRQTTM+14 -18YOY+23 -105Y+21 -1310Y+21 -13

3.3 Fundamental Score

Let's check the fundamental score of Biotest Aktiengesellschaft based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1526.721
Price to Book Ratio (EOD)Between0-11.935
Net Profit Margin (MRQ)Greater than00.062
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.497
Current Ratio (MRQ)Greater than12.453
Debt to Asset Ratio (MRQ)Less than10.610
Debt to Equity Ratio (MRQ)Less than11.567
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.007
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.178
Ma 20Greater thanMa 5027.075
Ma 50Greater thanMa 10026.758
Ma 100Greater thanMa 20026.717
OpenGreater thanClose26.200
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Biotest Aktiengesellschaft

Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infection; Fovepta for immunoprophylaxis of hepatitis B in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and Yimmugo for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, including neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B immunoglobulins. In addition, it provides Albiomin and Biseco to restore and maintain circulating blood volume; Cofact for deficiency of coagulation factors; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. Biotest Aktiengesellschaft is a subsidiary of Grifols, S.A.

Fundamental data was last updated by Penke on 2024-10-23 07:33:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biotest earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biotest to the Biotechnology industry mean.
  • A Net Profit Margin of 6.2% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 6.2%. The company is making a profit. +1
  • The TTM is 21.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ6.2%TTM21.5%-15.3%
TTM21.5%YOY-3.8%+25.3%
TTM21.5%5Y-1.4%+22.9%
5Y-1.4%10Y-1.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2%-135.4%+141.6%
TTM21.5%-201.5%+223.0%
YOY-3.8%-209.8%+206.0%
5Y-1.4%-359.0%+357.6%
10Y-1.4%-472.9%+471.5%
4.3.1.2. Return on Assets

Shows how efficient Biotest is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotest to the Biotechnology industry mean.
  • 0.7% Return on Assets means that Biotest generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.7%TTM3.5%-2.8%
TTM3.5%YOY-0.3%+3.7%
TTM3.5%5Y0.1%+3.4%
5Y0.1%10Y0.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%-10.7%+11.4%
TTM3.5%-11.7%+15.2%
YOY-0.3%-11.2%+10.9%
5Y0.1%-12.6%+12.7%
10Y0.1%-14.2%+14.3%
4.3.1.3. Return on Equity

Shows how efficient Biotest is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotest to the Biotechnology industry mean.
  • 1.8% Return on Equity means Biotest generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 10.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM10.0%-8.2%
TTM10.0%YOY-0.8%+10.8%
TTM10.0%5Y0.3%+9.7%
5Y0.3%10Y0.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-13.8%+15.6%
TTM10.0%-16.0%+26.0%
YOY-0.8%-13.6%+12.8%
5Y0.3%-18.5%+18.8%
10Y0.3%-19.0%+19.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biotest Aktiengesellschaft.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biotest is operating .

  • Measures how much profit Biotest makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotest to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.3%-2.3%
TTM-5Y-2.2%+2.2%
5Y-2.2%10Y-2.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--289.1%+289.1%
TTM--313.4%+313.4%
YOY2.3%-223.5%+225.8%
5Y-2.2%-386.0%+383.8%
10Y-2.2%-497.4%+495.2%
4.3.2.2. Operating Ratio

Measures how efficient Biotest is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.51 means that the operating costs are €1.51 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.511. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.328. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.511TTM1.328+0.183
TTM1.328YOY1.740-0.412
TTM1.3285Y1.698-0.370
5Y1.69810Y1.6980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5112.821-1.310
TTM1.3283.146-1.818
YOY1.7403.336-1.596
5Y1.6984.839-3.141
10Y1.6986.520-4.822
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biotest Aktiengesellschaft.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biotest is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.45 means the company has €2.45 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 2.453. The company is able to pay all its short-term debts. +1
  • The TTM is 2.863. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.453TTM2.863-0.410
TTM2.863YOY4.741-1.878
TTM2.8635Y4.430-1.567
5Y4.43010Y4.4300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4533.740-1.287
TTM2.8633.923-1.060
YOY4.7414.711+0.030
5Y4.4305.957-1.527
10Y4.4306.285-1.855
4.4.3.2. Quick Ratio

Measures if Biotest is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotest to the Biotechnology industry mean.
  • A Quick Ratio of 0.50 means the company can pay off €0.50 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.497. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.743. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.497TTM0.743-0.246
TTM0.743YOY1.312-0.570
TTM0.7435Y1.337-0.595
5Y1.33710Y1.3370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4973.326-2.829
TTM0.7433.510-2.767
YOY1.3124.633-3.321
5Y1.3375.927-4.590
10Y1.3376.479-5.142
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biotest Aktiengesellschaft.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biotest assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotest to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.61 means that Biotest assets are financed with 61.0% credit (debt) and the remaining percentage (100% - 61.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.610. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.638. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.610TTM0.638-0.027
TTM0.638YOY0.693-0.055
TTM0.6385Y0.636+0.002
5Y0.63610Y0.6360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6100.339+0.271
TTM0.6380.347+0.291
YOY0.6930.310+0.383
5Y0.6360.365+0.271
10Y0.6360.381+0.255
4.5.4.2. Debt to Equity Ratio

Measures if Biotest is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotest to the Biotechnology industry mean.
  • A Debt to Equity ratio of 156.7% means that company has €1.57 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.567. The company is just able to pay all its debts with equity.
  • The TTM is 1.768. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.567TTM1.768-0.200
TTM1.768YOY2.255-0.488
TTM1.7685Y1.782-0.015
5Y1.78210Y1.7820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5670.393+1.174
TTM1.7680.444+1.324
YOY2.2550.375+1.880
5Y1.7820.450+1.332
10Y1.7820.489+1.293
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biotest generates.

  • Above 15 is considered overpriced but always compare Biotest to the Biotechnology industry mean.
  • A PE ratio of 26.72 means the investor is paying €26.72 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 26.721. Based on the earnings, the company is overpriced. -1
  • The MRQ is 26.721. Based on the earnings, the company is overpriced. -1
  • The TTM is 11.550. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD26.721MRQ26.7210.000
MRQ26.721TTM11.550+15.171
TTM11.550YOY5.056+6.494
TTM11.5505Y-19.929+31.479
5Y-19.92910Y-19.9290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD26.721-2.472+29.193
MRQ26.721-2.481+29.202
TTM11.550-2.977+14.527
YOY5.056-3.435+8.491
5Y-19.929-5.847-14.082
10Y-19.929-6.262-13.667
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 4.438. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.438. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 11.271. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.438MRQ4.4380.000
MRQ4.438TTM11.271-6.833
TTM11.271YOY-10.252+21.523
TTM11.2715Y3.247+8.024
5Y3.24710Y3.2470.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.438-3.231+7.669
MRQ4.438-3.261+7.699
TTM11.271-3.497+14.768
YOY-10.252-4.550-5.702
5Y3.247-7.975+11.222
10Y3.247-8.686+11.933
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biotest is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.93 means the investor is paying €1.93 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 1.935. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.935. Based on the equity, the company is underpriced. +1
  • The TTM is 2.269. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.935MRQ1.9350.000
MRQ1.935TTM2.269-0.334
TTM2.269YOY3.617-1.348
TTM2.2695Y2.766-0.497
5Y2.76610Y2.7660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9351.996-0.061
MRQ1.9351.985-0.050
TTM2.2692.191+0.078
YOY3.6172.387+1.230
5Y2.7663.580-0.814
10Y2.7664.199-1.433
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,375,800
Total Liabilities839,900
Total Stockholder Equity535,900
 As reported
Total Liabilities 839,900
Total Stockholder Equity+ 535,900
Total Assets = 1,375,800

Assets

Total Assets1,375,800
Total Current Assets738,900
Long-term Assets636,900
Total Current Assets
Cash And Cash Equivalents 66,300
Short-term Investments 18,400
Net Receivables 131,300
Inventory 472,500
Other Current Assets 10,700
Total Current Assets  (as reported)738,900
Total Current Assets  (calculated)699,200
+/- 39,700
Long-term Assets
Property Plant Equipment 575,400
Long-term Assets Other 100
Long-term Assets  (as reported)636,900
Long-term Assets  (calculated)575,500
+/- 61,400

Liabilities & Shareholders' Equity

Total Current Liabilities301,200
Long-term Liabilities538,700
Total Stockholder Equity535,900
Total Current Liabilities
Accounts payable 69,400
Other Current Liabilities 17,200
Total Current Liabilities  (as reported)301,200
Total Current Liabilities  (calculated)86,600
+/- 214,600
Long-term Liabilities
Long-term Liabilities  (as reported)538,700
Long-term Liabilities  (calculated)0
+/- 538,700
Total Stockholder Equity
Retained Earnings 276,500
Total Stockholder Equity (as reported)535,900
Total Stockholder Equity (calculated)276,500
+/- 259,400
Other
Capital Stock39,600
Common Stock Shares Outstanding 39,571
Net Invested Capital 535,900
Net Working Capital 437,700
Property Plant and Equipment Gross 575,400



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
1,091,000
1,108,400
1,107,600
1,145,200
1,122,200
1,131,300
1,134,800
1,145,800
1,135,400
1,104,200
1,109,800
1,101,900
1,079,300
1,203,000
1,190,200
1,214,100
1,349,500
1,410,900
1,446,800
1,375,800
1,375,8001,446,8001,410,9001,349,5001,214,1001,190,2001,203,0001,079,3001,101,9001,109,8001,104,2001,135,4001,145,8001,134,8001,131,3001,122,2001,145,2001,107,6001,108,4001,091,000
   > Total Current Assets 
508,500
522,800
525,600
563,900
542,200
556,300
560,600
570,500
556,600
522,200
523,900
522,000
497,500
619,400
597,400
620,700
736,200
756,500
796,200
738,900
738,900796,200756,500736,200620,700597,400619,400497,500522,000523,900522,200556,600570,500560,600556,300542,200563,900525,600522,800508,500
       Cash And Cash Equivalents 
65,500
60,800
44,000
63,700
40,200
71,300
55,000
72,000
79,200
104,400
115,300
85,000
53,300
116,600
68,000
58,300
65,400
108,100
84,700
66,300
66,30084,700108,10065,40058,30068,000116,60053,30085,000115,300104,40079,20072,00055,00071,30040,20063,70044,00060,80065,500
       Short-term Investments 
34,100
24,900
20,600
31,000
32,800
17,900
13,300
13,100
12,100
13,100
14,800
18,100
23,600
20,000
18,900
12,600
13,400
10,400
14,100
18,400
18,40014,10010,40013,40012,60018,90020,00023,60018,10014,80013,10012,10013,10013,30017,90032,80031,00020,60024,90034,100
       Net Receivables 
104,800
167,100
139,000
156,500
152,600
179,200
171,800
168,900
155,100
160,800
120,000
140,300
128,300
124,500
120,400
193,400
210,300
145,200
201,000
131,300
131,300201,000145,200210,300193,400120,400124,500128,300140,300120,000160,800155,100168,900171,800179,200152,600156,500139,000167,100104,800
       Inventory 
257,300
280,100
312,400
304,300
306,900
290,100
301,800
303,100
298,100
244,600
255,800
263,200
268,700
293,800
327,600
341,100
373,600
419,100
438,700
472,500
472,500438,700419,100373,600341,100327,600293,800268,700263,200255,800244,600298,100303,100301,800290,100306,900304,300312,400280,100257,300
       Other Current Assets 
6,900
2,300
9,600
8,400
9,700
3,400
18,700
13,400
24,200
3,700
32,800
33,500
47,200
3,100
20,400
27,900
29,300
2,700
12,200
10,700
10,70012,2002,70029,30027,90020,4003,10047,20033,50032,8003,70024,20013,40018,7003,4009,7008,4009,6002,3006,900
   > Long-term Assets 
582,500
585,600
582,000
581,300
580,000
575,000
574,200
575,300
578,800
582,000
585,900
579,900
581,800
583,600
592,700
593,400
613,300
654,400
650,600
636,900
636,900650,600654,400613,300593,400592,700583,600581,800579,900585,900582,000578,800575,300574,200575,000580,000581,300582,000585,600582,500
       Property Plant Equipment 
541,800
320,300
545,000
546,100
546,000
311,300
547,200
546,600
547,400
476,700
547,800
544,600
543,800
547,800
549,600
555,700
573,400
578,400
581,100
575,400
575,400581,100578,400573,400555,700549,600547,800543,800544,600547,800476,700547,400546,600547,200311,300546,000546,100545,000320,300541,800
       Goodwill 
0
7,200
0
0
0
7,100
0
0
0
7,100
0
0
0
7,200
0
0
0
6,000
0
0
006,0000007,2000007,1000007,1000007,2000
       Intangible Assets 
0
6,600
0
0
0
6,900
0
0
0
4,100
0
0
0
9,200
0
0
0
9,000
0
0
009,0000009,2000004,1000006,9000006,6000
       Other Assets 
14,900
251,600
13,600
12,000
11,400
249,700
10,700
12,600
15,300
90,400
22,200
19,700
21,300
0
0
17,100
0
0
0
0
000017,1000021,30019,70022,20090,40015,30012,60010,700249,70011,40012,00013,600251,60014,900
> Total Liabilities 
599,300
631,500
641,400
685,900
678,000
689,700
707,100
723,400
723,200
723,800
734,700
743,200
735,500
831,900
839,100
840,600
889,600
912,000
918,900
839,900
839,900918,900912,000889,600840,600839,100831,900735,500743,200734,700723,800723,200723,400707,100689,700678,000685,900641,400631,500599,300
   > Total Current Liabilities 
101,100
115,000
123,100
113,800
103,300
105,600
121,100
111,100
103,800
106,400
114,900
122,200
109,600
130,200
129,500
122,800
147,200
385,300
391,200
301,200
301,200391,200385,300147,200122,800129,500130,200109,600122,200114,900106,400103,800111,100121,100105,600103,300113,800123,100115,000101,100
       Short Long Term Debt 
0
3,300
0
0
0
3,500
0
0
0
29,500
0
0
0
4,800
0
0
0
226,800
0
0
00226,8000004,80000029,5000003,5000003,3000
       Accounts payable 
40,100
52,200
54,700
49,000
37,700
42,000
49,300
43,800
31,500
38,800
38,700
42,200
30,200
51,100
44,700
54,500
53,300
78,100
77,200
69,400
69,40077,20078,10053,30054,50044,70051,10030,20042,20038,70038,80031,50043,80049,30042,00037,70049,00054,70052,20040,100
       Other Current Liabilities 
30,400
55,300
62,500
56,700
57,800
55,700
63,300
58,300
63,500
25,100
40,300
40,300
37,300
4,900
21,100
34,700
20,800
5,800
16,500
17,200
17,20016,5005,80020,80034,70021,1004,90037,30040,30040,30025,10063,50058,30063,30055,70057,80056,70062,50055,30030,400
   > Long-term Liabilities 
498,200
516,500
518,300
572,100
574,700
584,100
586,000
612,300
619,400
617,400
619,800
621,000
625,900
701,700
709,600
717,800
742,400
526,700
527,700
538,700
538,700527,700526,700742,400717,800709,600701,700625,900621,000619,800617,400619,400612,300586,000584,100574,700572,100518,300516,500498,200
       Long term Debt 
0
379,600
0
0
0
438,200
0
0
0
473,400
0
0
0
540,500
0
0
0
329,500
0
0
00329,500000540,500000473,400000438,200000379,6000
       Capital Lease Obligations Min Short Term Debt
0
26,700
0
0
0
27,400
0
0
0
26,800
0
0
0
29,000
0
0
0
57,800
0
0
0057,80000029,00000026,80000027,40000026,7000
       Other Liabilities 
94,400
113,600
112,400
112,900
114,100
121,600
122,300
122,700
123,100
121,000
121,700
120,900
121,700
0
0
89,300
0
0
0
0
000089,30000121,700120,900121,700121,000123,100122,700122,300121,600114,100112,900112,400113,60094,400
       Long-term Liabilities Other 
200
300
100
0
0
-600
0
0
0
-1,900
0
0
100
-700
0
0
0
-300
0
0
00-300000-70010000-1,900000-60000100300200
> Total Stockholder Equity
491,700
476,900
466,200
459,300
444,200
441,600
427,700
422,400
412,200
380,400
375,100
358,700
343,800
371,100
351,100
373,500
459,900
498,900
527,900
535,900
535,900527,900498,900459,900373,500351,100371,100343,800358,700375,100380,400412,200422,400427,700441,600444,200459,300466,200476,900491,700
   Common Stock
39,600
39,600
39,600
39,600
39,600
39,600
39,600
39,600
39,600
39,600
39,600
39,600
39,600
0
0
39,600
0
0
0
0
000039,6000039,60039,60039,60039,60039,60039,60039,60039,60039,60039,60039,60039,60039,600
   Retained Earnings 
232,300
221,400
206,800
203,900
184,800
185,100
168,300
166,000
152,800
123,000
115,700
135,000
84,400
111,700
91,700
124,500
200,500
239,500
268,500
276,500
276,500268,500239,500200,500124,50091,700111,70084,400135,000115,700123,000152,800166,000168,300185,100184,800203,900206,800221,400232,300
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 0000-10,400000-35,7000-2,0000-3,0000-2,9000-4,0000-3,9000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue684,600
Cost of Revenue-404,300
Gross Profit280,300280,300
 
Operating Income (+$)
Gross Profit280,300
Operating Expense-564,500
Operating Income120,100-284,200
 
Operating Expense (+$)
Research Development66,800
Selling General Administrative81,000
Selling And Marketing Expenses0
Operating Expense564,500147,800
 
Net Interest Income (+$)
Interest Income2,000
Interest Expense-40,000
Other Finance Cost-200
Net Interest Income-38,200
 
Pretax Income (+$)
Operating Income120,100
Net Interest Income-38,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)106,300120,100
EBIT - interestExpense = -40,000
127,000
167,000
Interest Expense40,000
Earnings Before Interest and Taxes (EBIT)0146,300
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax106,300
Tax Provision--20,700
Net Income From Continuing Ops127,000127,000
Net Income127,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net038,200
 

Technical Analysis of Biotest
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotest. The general trend of Biotest is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotest's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotest Aktiengesellschaft.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 26.50 < 26.50 < 26.50.

The bearish price targets are: 25.40 > 24.90 > 24.80.

Tweet this
Biotest Aktiengesellschaft Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotest Aktiengesellschaft. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotest Aktiengesellschaft Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotest Aktiengesellschaft. The current macd is -0.19867223.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotest price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biotest. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biotest price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) ChartBiotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotest Aktiengesellschaft. The current adx is 18.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biotest shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Biotest Aktiengesellschaft Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotest Aktiengesellschaft. The current sar is 27.33.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biotest Aktiengesellschaft Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotest Aktiengesellschaft. The current rsi is 38.18. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Biotest Aktiengesellschaft Daily Relative Strength Index (RSI) ChartBiotest Aktiengesellschaft Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotest Aktiengesellschaft. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotest price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biotest Aktiengesellschaft Daily Stochastic Oscillator ChartBiotest Aktiengesellschaft Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotest Aktiengesellschaft. The current cci is -110.58451817.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Biotest Aktiengesellschaft Daily Commodity Channel Index (CCI) ChartBiotest Aktiengesellschaft Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotest Aktiengesellschaft. The current cmo is -34.34967827.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) ChartBiotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotest Aktiengesellschaft. The current willr is -83.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Biotest Aktiengesellschaft Daily Williams %R ChartBiotest Aktiengesellschaft Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotest Aktiengesellschaft. The current atr is 0.20417622.

Biotest Aktiengesellschaft Daily Average True Range (ATR) ChartBiotest Aktiengesellschaft Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotest Aktiengesellschaft. The current obv is -10,704.

Biotest Aktiengesellschaft Daily On-Balance Volume (OBV) ChartBiotest Aktiengesellschaft Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotest Aktiengesellschaft. The current mfi is 28.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biotest Aktiengesellschaft Daily Money Flow Index (MFI) ChartBiotest Aktiengesellschaft Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotest Aktiengesellschaft.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Biotest Aktiengesellschaft Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.178
Ma 20Greater thanMa 5027.075
Ma 50Greater thanMa 10026.758
Ma 100Greater thanMa 20026.717
OpenGreater thanClose26.200
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biotest with someone you think should read this too:
  • Are you bullish or bearish on Biotest? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotest? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.


Comments

How you think about this?

Leave a comment

Stay informed about Biotest Aktiengesellschaft.

Receive notifications about Biotest Aktiengesellschaft in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.